Sankey It
Loading...
Eli Lilly and Company FY2021 income statement | Sankey It
Sankey It · LLY
Eli Lilly and Company FY2021 income statement
USD · fiscal year ended 2021-12-31
FY2025
FY2024
FY2023
FY2022
FY2021
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Eli Lilly and Company FY2021 income statement
Flow diagram with 10 nodes and 9 flows for Eli Lilly and Company FY2021 income statement. Values: Product US$26B, Collaboration and Other Revenue US$2.4B, Revenue US$28.3B, Cost of Revenue US$7.3B, Gross Profit US$21B, Operating Expenses US$13.1B, Operating Income US$7.9B, Other Expense US$1.8B, Tax US$573.8M, Net Income US$5.6B.
Product
US$26B
92% of revenue
Collaboration and Other Revenue
US$2.4B
8% of revenue
Revenue
US$28.3B
Cost of Revenue
(US$7.3B)
26% of revenue
Gross Profit
US$21B
74% margin
Operating Expenses
(US$13.1B)
46% of revenue
Operating Income
US$7.9B
28% margin
Other Expense
(US$1.8B)
6% of revenue
Tax
(US$573.8M)
2% of revenue
Net Income
US$5.6B
20% margin
Net / profit
Inputs
Tax / cost
Copy link
Share on X
Open full screen